BeStock  

10x Genomics TXG

US equityMarket cap rank #1749AI medical concept stocks
$51.80 −$5.58 (-9.72%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $51.01 -1.53%
Open$55.77
Prev close$57.38
Day range$51.30 – $56.44
Volume3.23M
Market cap$6.81B
P/E (TTM)–
Dividend yield–

Fundamentals

Latest reported quarter: Q3, ended Sep 2026

Revenue$150.67M+1.1% YoY
Operating profit-$16.06M+50.2% YoY
Net profit-$19.43M+29.3% YoY
Diluted EPS-$0.15+31.8% YoY
Free cash flow$14.86M-65.1% YoY
Operating cash flow$15.83M

Revenue, last 8 quarters

$165.0MDec '24$154.9MMar '25$172.9MJun '25$149.0MSep '25$166.0MDec '25$150.8MMar '26$151.0MJun '26$150.7MSep '26

Net profit, last 8 quarters

$-49.0MDec '24$-34.4MMar '25$34.5MJun '25$-27.5MSep '25$-16.3MDec '25$-13.5MMar '26$-17.9MJun '26$-19.4MSep '26

Diluted EPS by quarter

-0.40Dec '24-0.28Mar '250.28Jun '25-0.22Sep '25-0.13Dec '25-0.10Mar '26-0.14Jun '26-0.15Sep '26

Free cash flow by quarter

$-9.5MDec '24$32.5MMar '25$16.1MJun '25$42.5MSep '25$39.0MDec '25$24.5MMar '26$15.4MJun '26$14.9MSep '26

Annual revenue

$298.8MFY20$490.5MFY21$516.4MFY22$618.7MFY23$610.8MFY24$642.8MFY25

Profitability & balance sheet

Gross margin71.9%
Operating margin-12.2%
Net margin-10.8%
Return on equity-8.3%
Return on assets-6.4%
Return on invested capital-9.0%
Current ratio5.12
Liabilities / assets21.2%
Cash & investments$575.68M
Total debt$63.85M
Net cash (debt)$511.83M
Free cash flow / sales15.2%

Income statement

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Revenue as Reported $150.67M $151.04M $150.84M $642.82M $166.03M
Total Operating Revenue $150.67M $151.04M $150.84M $642.82M $166.03M
Cost of Revenue $37.74M $38.54M $44.67M $198.94M $52.99M
Gross Profit $112.93M $112.50M $106.18M $443.88M $113.05M
Operating Expense $128.98M $135.45M $123.22M $554.77M $132.59M
Selling and Admin Expenses $76.06M $78.66M $66.38M $316.13M $76.62M
Research & Development $52.93M $56.79M $56.85M $238.63M $55.97M
Operating Profit -$16.06M -$22.96M -$17.05M -$110.89M -$19.54M
Net Non-Operating Interest Income (Expense) $5.02M $4.80M $5.01M $20.05M $6.89M
Non-Operating Interest Income $5.02M $4.80M $5.01M $20.05M $6.89M
Non-Operating Interest Expense $0.00 $0.00 – $0.00 $0.00
Other Income (Expense) -$7.44M -$487,000.00 -$815,000.00 $50.93M -$2.54M
Special Income (Charges) $0.00 $3.40M $0.00 $49.90M $0.00
Other Non-Operating Income (Expenses) -$7.44M -$3.89M -$815,000.00 $1.03M -$2.54M
Pretax Profit -$18.48M -$18.65M -$12.85M -$39.91M -$15.19M
Tax $949,000.00 -$714,000.00 $623,000.00 $3.64M $1.06M
Net Profit -$19.43M -$17.93M -$13.47M -$43.54M -$16.25M
Profit from Continuing Operations -$19.43M -$17.93M -$13.47M -$43.54M -$16.25M
Net Income to Parent Company -$19.43M -$17.93M -$13.47M -$43.54M -$16.25M
Net Income to Common Stockholders -$19.43M -$17.93M -$13.47M -$43.54M -$16.25M
Basic EPS -$0.15 -$0.14 -$0.10 -$0.35 -$0.13
Diluted EPS -$0.15 -$0.14 -$0.10 -$0.35 -$0.13
-Less:Other Special Charges – -$3.40M – -$49.90M $0.00

Balance sheet

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Assets $1.06B $1.03B $1.02B $1.04B $1.04B
Total Current Assets $718.63M $674.67M $669.73M $684.45M $684.45M
Cash and Cash Equivalents & Short-Term Investments $575.68M $552.03M $539.85M $523.41M $523.41M
-Cash and Cash Equivalents $526.19M $502.51M $490.29M $473.97M $473.97M
-Short Term Investments $49.49M $49.52M $49.56M $49.44M $49.44M
Receivables $58.76M $50.63M $56.14M $82.49M $82.49M
-Accounts Receivable $55.70M $47.55M $39.03M $47.01M $47.01M
-Other Receivables $3.06M $3.08M $17.11M $35.48M $35.48M
Inventory $64.63M $52.62M $53.49M $56.34M $56.34M
Other Current Assets $19.57M $19.39M $20.26M $22.21M $22.21M
Total Non-Current Assets $344.50M $355.40M $346.03M $356.91M $356.91M
Net PPE $265.00M $272.01M $278.98M $287.16M $287.16M
-Gross PPE $439.76M $439.77M $439.93M $440.63M $440.63M
-Accumulated Depreciation -$174.76M -$167.76M -$160.95M -$153.46M -$153.46M
Goodwill and Other Intangible Assets $65.58M $68.08M $64.42M $66.84M $66.84M
-Goodwill $6.92M $6.92M $4.51M $4.51M $4.51M
-Other Intangible Assets $58.66M $61.16M $59.91M $62.33M $62.33M
Other Non-Current Assets $13.92M $15.31M $2.62M $2.91M $2.91M
Total Liabilities $225.09M $204.52M $201.44M $245.04M $245.04M
Total Current Liabilities $140.37M $118.51M $113.60M $153.45M $153.45M
Payables $32.07M $30.22M $27.77M $25.49M $25.49M
-Accounts Payable $21.59M $20.69M $17.43M $12.73M $12.73M
-Total Tax Payable $6.98M $6.95M $6.52M $7.22M $7.22M
-Other Payable $3.50M $2.58M $3.82M $5.54M $5.54M
Current Accrued Expenses $21.59M $16.01M $18.87M $19.81M $19.81M
Short-Term Debt and Capital Lease Obligation $11.95M $12.02M $11.33M $10.99M $10.99M
-Current Capital Lease Obligation $11.95M $12.02M $11.33M $10.99M $10.99M
Current Deferred Liabilities $22.96M $23.61M $24.34M $23.90M $23.90M
Other Current Liabilities $23.61M $18.07M $19.44M $41.06M $41.06M
Total Non-Current Liabilities $84.72M $86.01M $87.84M $91.59M $91.59M
Long Term Debt and Capital Lease Obligation $63.85M $66.78M $70.06M $73.38M $73.38M
-Long Term Capital Lease Obligation $63.85M $66.78M $70.06M $73.38M $73.38M
Non-Current Deferred Liabilities $8.53M $9.68M $10.14M $10.50M $10.50M
Other Non-Current Liabilities $12.35M $9.55M $7.64M $7.71M $7.71M
Total Equity $838.04M $825.55M $814.32M $796.33M $796.33M
Stockholders' Equity $838.04M $825.55M $814.32M $796.33M $796.33M
Capital Stock $2,000.00 $2,000.00 $2,000.00 $2,000.00 $2,000.00
-Common Stock $2,000.00 $2,000.00 $2,000.00 $2,000.00 $2,000.00
-Preferred Stock $0.00 $0.00 $0.00 $0.00 $0.00
Additional Paid-In Capital $2.40B $2.37B $2.34B $2.31B $2.31B
Retained Earnings -$1.56B -$1.54B -$1.52B -$1.51B -$1.51B
Gains/Losses Not Affecting Retained Earnings $197,000.00 $77,000.00 $114,000.00 $225,000.00 $225,000.00

Cash flow

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Operating Cash Flow $15.83M $16.97M $26.12M $136.05M $40.78M
Net cash flow from continuing operations $15.83M $16.97M $26.12M $136.05M $40.78M
Net Income from Continuing Operations -$19.43M -$17.93M -$13.47M -$43.54M -$16.25M
Depreciation & Depletion & Amortization $11.61M $11.68M $11.91M $43.82M $12.10M
Deferred Tax $0.00 – – – –
Other Non-Cash Items $7.47M $3.10M -$250,000.00 -$346,000.00 -$121,000.00
Change in Working Capital -$6.92M -$4.06M $5.29M $24.94M $18.58M
-Change in Receivables -$8.12M $5.50M $26.11M $6.44M $14.10M
-Change in Inventory -$12.21M $3.00M $2.70M $27.95M $5.58M
-Change in Prepaid Assets -$1.18M $1.21M $1.95M -$2.34M -$2.99M
-Change in Payables and Accrued Expense $2.65M -$268,000.00 -$1.97M -$7.28M -$632,000.00
-Change in Other Current Assets $2.08M -$12.21M $282,000.00 $689,000.00 -$1.60M
-Change in Other Current Liabilities -$3.26M -$2.83M -$2.90M -$8.91M -$2.65M
-Change In Other Working Capital $13.13M $1.54M -$20.88M $8.39M $6.76M
Net cash flow from investing -$503,000.00 -$7.74M -$1.31M -$13.44M -$1.81M
Net Cash Flow from Continuing Investing Activities -$503,000.00 -$7.74M -$1.31M -$13.44M -$1.81M
Net PPE Purchase and Sale -$971,000.00 -$1.59M -$1.60M -$5.94M -$1.78M
Net Business Purchase and Sale $0.00 – – – –
Net Investment Purchase and Sale $468,000.00 $454,000.00 $286,000.00 $1.77M $624,000.00
Financing Cash Flow $8.53M $3.02M -$8.42M $6.80M $2.24M
Net Cash Flow from Continuing Financing Activities $8.53M $3.02M -$8.42M $6.80M $2.24M
Proceeds from Stock Option Exercised $8.53M $3.02M $273,000.00 $6.80M $2.24M
Net Other Financing Charges $0.00 $0.00 -$8.69M – –
Ending Cash Balance $526.19M $502.51M $490.29M $473.97M $473.97M
Net Change in Cash $23.86M $12.26M $16.39M $129.42M $41.21M
Beginning Cash Balance $502.51M $490.29M $473.97M $344.07M $432.71M
Effect of Exchange Rate Changes -$181,000.00 -$28,000.00 -$73,000.00 $484,000.00 $43,000.00
Free Cash Flow $14.86M $15.39M $24.52M $130.12M $39.00M
Net Intangibles Purchase and Sale – – – $0.00 $0.00
Net Other Investing Changes – – – -$9.27M -$652,000.00

Discussion

No comments yet — be the first to weigh in on TXG.

Sign in to join the discussion.

Scroll to Top